X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AMAR REMEDIES with UNILEVER PLC. - UK - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs UNILEVER PLC. (UK) - Comparison Results

UNILEVER PLC. (UK)
   Change

Unilever is an Anglo–Dutch multinational consumer goods company. It is present in 11 categories broadly divided into home care, personal care, refreshments and foods. Personal care and foods are the large segments with sales shares of 35% and 28%, re... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AMAR REMEDIES   UNILEVER PLC.
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
UNILEVER PLC.
Dec-14
AMAR REMEDIES/
UNILEVER PLC.
5-Yr Chart
Click to enlarge
High Rs1642,593-   
Low Rs862,102-   
Sales per share (Unadj.) Rs261.62,187.4-  
Earnings per share (Unadj.) Rs17.4249.1-  
Cash flow per share (Unadj.) Rs22.3300.0-  
Dividends per share (Unadj.) Rs086.73-  
Dividend yield (eoy) %03.7 0.0%  
Book value per share (Unadj.) Rs100.7616.5-  
Shares outstanding (eoy) m26.161,714.73-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.51.1 44.5%   
Avg P/E ratio x7.29.4 76.2%  
P/CF ratio (eoy) x5.67.8 71.7%  
Price / Book Value ratio x1.23.8 32.6%  
Dividend payout %034.8 0.0%   
Avg Mkt Cap Rs m3,2704,026,153 0.1%   
No. of employees `000NA173.0 0.0%   
Total wages/salary Rs m163468,822 0.0%   
Avg. sales/employee Rs ThNM21,681.4-  
Avg. wages/employee Rs ThNM2,710.0-  
Avg. net profit/employee Rs ThNM2,468.7-  
INCOME DATA
Net Sales Rs m6,8443,750,884 0.2%  
Other income Rs m2112,545 0.2%   
Total revenues Rs m6,8653,763,429 0.2%   
Gross profit Rs m1,131732,195 0.2%  
Depreciation Rs m12887,275 0.1%   
Interest Rs m39838,720 1.0%   
Profit before tax Rs m626618,746 0.1%   
Minority Interest Rs m0-26,639 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121165,025 0.1%   
Profit after tax Rs m455427,082 0.1%  
Gross profit margin %16.519.5 84.7%  
Effective tax rate %19.326.7 72.5%   
Net profit margin %6.611.4 58.4%  
BALANCE SHEET DATA
Current assets Rs m4,904956,152 0.5%   
Current liabilities Rs m3,5811,521,076 0.2%   
Net working cap to sales %19.3-15.1 -128.3%  
Current ratio x1.40.6 217.9%  
Inventory Days Days12431 395.6%  
Debtors Days Days10038 264.3%  
Net fixed assets Rs m1,689810,952 0.2%   
Share capital Rs m26237,481 0.7%   
"Free" reserves Rs m2,3580-   
Net worth Rs m2,6351,057,133 0.2%   
Long term debt Rs m507556,484 0.1%   
Total assets Rs m6,8623,619,623 0.2%  
Interest coverage x2.617.0 15.2%   
Debt to equity ratio x0.20.5 36.6%  
Sales to assets ratio x1.01.0 96.2%   
Return on assets %12.412.9 96.6%  
Return on equity %17.340.4 42.7%  
Return on capital %31.039.1 79.3%  
Exports to sales %4.00-   
Imports to sales %00-   
Net fx Rs m2710-   
CASH FLOW
From Operations Rs m-313429,250 -0.1%  
From Investments Rs m-489-26,407 1.8%  
From Financial Activity Rs m769-401,914 -0.2%  
Net Cashflow Rs m-33929 -3.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for UNILEVER PLC. (UK) is Euro. All data has been converted at 77.44 Rs / EUR

Compare AMAR REMEDIES With: P&G (US)  HYPERMARCAS (Brazil)  

Compare AMAR REMEDIES With: GODREJ CONSUMER  K.S.OILS LTD  EMAMI LTD  GODREJ INDUSTRIES  KARUTURI GLOBAL  



Today's Market

Indian Indices Dip After Record Rally; Sensex Ends 298 Points Lower(Closing)

It was a volatile day for Indian share markets today. The BSE Sensex and NSE Nifty opened at record high and went on to touch 40,000 and 12,000.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS